A Systems Pharmacology-Based Study of the Molecular Mechanisms of San Cao Decoction for Treating Hypertension. (2nd July 2019)

• Record Type: Journal Article
• Authors: Ma, Chongyang; Zhai, Changming; Xu, Tian; Lu, Fang; Zhang, Shuang; Li, Changxiang; Wang, Qingguo; Cheng, Fafeng; Wang, Xueqian
• Other Names: Kek Teh Ley Academic Editor.
• Is Part Of: Evidence-based complementary and alternative medicine. Volume 2019(2019)
• Publication Date: 2019-07-02
• Subjects: Alternative medicine -- Periodicals; 615.505
• DOI: 10.1155/2019/3171420
• Languages: English
• ISSNs: 1741-427X

Abstract

Abstract : Traditional Chinese medicine (TCM) has a longstanding history and has gained widespread clinical applications. San Cao Decoction (SCD) is an experience prescription first formulated by Prof. Duzhou Liu. We previously demonstrated its antihypertensive effects; however, to systematically explain the underlying mechanisms of action, we employed a systems pharmacology approach for pharmacokinetic screening and target prediction by constructing protein-protein interaction networks of hypertension-related and putative SCD-related targets, and Database for Annotation, Visualization, and Integrated Discovery enrichment analysis. We identified 123 active compounds in SCD and 116 hypertension-related targets. Furthermore, the enrichment analysis of the drug-target network showed that SCD acts in a multidimensional manner to regulate PI3K-Akt-endothelial nitric oxide synthase signaling to maintain blood pressure. Our results highlighted the molecular mechanisms of antihypertensive actions of medicinal herbs at a systematic level.